AEs: the percentage and number (out of 28 evaluable patients) of patients with specified AEs (any grade and grades greater than 3 only) limited to possible or greater attribution
| AE . | Any grade, % (n) . | Grade ≥3, % (n) . |
|---|---|---|
| Neutrophil count decreased | 85.7 (24) | 75 (21) |
| Platelet count decreased | 60.7 (17) | 60.7 (17) |
| Anemia | 50 (14) | 32.1 (9) |
| Febrile neutropenia | 14.3 (4) | 14.3 (4) |
| Tumor lysis syndrome | 14.3 (4) | 14.3 (4) |
| Hypokalemia | 28.6 (8) | 10.7 (3) |
| White blood cell count decreased | 21.4 (6) | 10.7 (3) |
| Lymphocyte count decreased | 14.3 (4) | 10.7 (3) |
| Diarrhea | 75 (21) | 7.1 (2) |
| Fatigue | 71.4 (20) | 7.1 (2) |
| Upper respiratory infection | 25 (7) | 3.6 (1) |
| Dysgeusia | 42.9 (12) | 0 (0) |
| Nausea | 42.9 (12) | 0 (0) |
| Headache | 39.3 (11) | 0 (0) |
| Bruising | 28.6 (8) | 0 (0) |
| Constipation | 28.6 (8) | 0 (0) |
| Pruritus | 28.6 (8) | 0 (0) |
| Abdominal pain | 25 (7) | 0 (0) |
| Maculo-papular rash | 25 (7) | 0 (0) |
| AE . | Any grade, % (n) . | Grade ≥3, % (n) . |
|---|---|---|
| Neutrophil count decreased | 85.7 (24) | 75 (21) |
| Platelet count decreased | 60.7 (17) | 60.7 (17) |
| Anemia | 50 (14) | 32.1 (9) |
| Febrile neutropenia | 14.3 (4) | 14.3 (4) |
| Tumor lysis syndrome | 14.3 (4) | 14.3 (4) |
| Hypokalemia | 28.6 (8) | 10.7 (3) |
| White blood cell count decreased | 21.4 (6) | 10.7 (3) |
| Lymphocyte count decreased | 14.3 (4) | 10.7 (3) |
| Diarrhea | 75 (21) | 7.1 (2) |
| Fatigue | 71.4 (20) | 7.1 (2) |
| Upper respiratory infection | 25 (7) | 3.6 (1) |
| Dysgeusia | 42.9 (12) | 0 (0) |
| Nausea | 42.9 (12) | 0 (0) |
| Headache | 39.3 (11) | 0 (0) |
| Bruising | 28.6 (8) | 0 (0) |
| Constipation | 28.6 (8) | 0 (0) |
| Pruritus | 28.6 (8) | 0 (0) |
| Abdominal pain | 25 (7) | 0 (0) |
| Maculo-papular rash | 25 (7) | 0 (0) |
Only AEs with an overall incidence of 25% and/or with a grade ≥3 incidence of 10% are shown.